livescience - A young girl in China died after being given an experimental gene therapy intended to treat a neurodevelopmental syndrome, an investigation by Science and Retraction Watch revealed.
AI Summary: An investigation found a six‑year‑old patient died following an experimental gene‑editing treatment in China, and that the fatality was not promptly disclosed. The case has reignited scrutiny of the country’s gene therapy oversight and raised urgent questions about trial transparency, consent and regulatory enforcement.
Single‑infusion gene editing dramatically lowers LDL cholesterol in early trial / 7 wks
AI model identifies improved cancer outcomes globally / 6 months
Scientists precisely edit human embryo genes, reigniting safety debate / 7 wks
Gene therapy restores hearing in about 90% of trial participants / 3 months
FDA scrutinizes peptide injections popularized by RFK Jr. and influencers / 47 hrs
Personalized genetic therapy yields improvements in children with rare epilepsy / 2 days
White House proposes double-digit HHS cuts and reorganization plan / 3 months
StackHealth RSS


StackHealth Time Machine
NorthFeed Inc. Terms and Conditions / Privacy Policy
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.